The stock price for Evoke Pharma Inc (EVOK) currently stands at $6.34. The stock experienced a substantial increase in the last session, hitting $18.0 after starting at $6.34. The stock’s lowest price was $18.0 before closing at $5.83.
The market performance of Evoke Pharma Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $12.32 on 10/28/24, while the lowest value for the same duration was $1.94 on 04/15/25.
52-week price history of EVOK Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Evoke Pharma Inc’s current trading price is -48.54% away from its 52-week high, while its distance from the 52-week low is 226.80%. The stock’s price range during the 52-week period has remained between $1.94 and $12.32. In the Healthcare sector, the company’s shares saw a trading volume of around 7.52 million for the day, which was evidently higher than the average daily volume of 2.34 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Evoke Pharma Inc (EVOK) has experienced a quarterly rise of 83.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.89M and boasts a workforce of 3 employees.
A Closer Look at Analysts’ Ratings for Evoke Pharma Inc
As of right now, 0 analyst is rating Evoke Pharma Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.59, with a change in price of +3.55. Similarly, Evoke Pharma Inc recorded 1,554,833 in trading volume during the last 100 days, posting a change of +127.24%.
Examining EVOK’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for EVOK stands at 1.17. Similarly, the long-term debt-to-equity ratio is also 0.02.
EVOK Stock Stochastic Average
Evoke Pharma Inc’s raw stochastic average for the past 50 days is presently 52.29%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 80.61%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 88.91% and 91.38%, respectively.
EVOK Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 6.55%. However, over the past six months, we’ve seen a weaker performance of 20.63%. The price of EVOK fallen by 40.27% over the last 30 days. And in the last five days, it has surged by 23.35%.
